Myriad Genetics Inc
(LTS:0K3W)
$
13.635
0.293 (2.19%)
Market Cap: 1.24 Bil
Enterprise Value: 1.29 Bil
PE Ratio: 0
PB Ratio: 1.70
GF Score: 63/100 Myriad Genetics Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 10:00PM GMT
Release Date Price:
$21.63
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Good afternoon, everyone. I'm Derik De Bruin, the senior life sciences and diagnostics analyst here at Bank of America. Welcome to our 2023 Healthcare Conference and coming to you live from the Encore here in fabulous Las Vegas. It's my great pleasure to welcome Myriad Genetics and Paul Diaz, President and CEO of the company. Paul, thank you for being here.
Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director
Thank you, Derik. Appreciate the opportunity.
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
So I have a long history with Myriad. I have covered their stock in some form since 2001.
Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director
We're quite a different organization these days.
Questions & Answers
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
So
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot